C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.330
+0.090 (4.02%)
At close: Aug 13, 2025, 4:00 PM
2.340
+0.010 (0.43%)
After-hours: Aug 13, 2025, 7:59 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $165.83 million as of August 13, 2025. Its market cap has decreased by -63.15% in one year.
Market Cap
165.83M
Enterprise Value
9.34M
1-Year Change
-63.15%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $165.83M, a decrease of -78.54%. That is a compound annual growth rate of -27.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 165.83M | -34.74% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |